MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression. - Wikidata - awgldk - TriplyDB

MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression.

MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression.

http://www.wikidata.org/entity/Q34960600

about

Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 transcription factor-mediated control of cyclin transcription Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old Depletion of the aryl hydrocarbon receptor in MDA-MB-231 human breast cancer cells altered the expression of genes in key regulatory pathways of cancer Osteosarcomagenesis: modeling cancer initiation in the mouse.Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins.Polymeric immunoglobulin receptor expression is correlated with poor prognosis in patients with osteosarcoma.MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo.Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency.A multilevel model to address batch effects in copy number estimation using SNP arrays.A molecular signature of normal breast epithelial and stromal cells from Li-Fraumeni syndrome mutation carriers.Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.Role of miR-204 in the regulation of apoptosis, endoplasmic reticulum stress response, and inflammation in human trabecular meshwork cells.Identification of putative target genes of the transcription factor RUNX2.Apoptotic cell signaling in cancer progression and therapy Survivin and IAP proteins in cell-death mechanisms A new therapeutic basis for treating Li-Fraumeni Syndrome breast tumors expressing mutated TP53.IL-17A/IL-17RA interaction promoted metastasis of osteosarcoma cells.Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis.IAP antagonists sensitize murine osteosarcoma cells to killing by TNFα Heritable one-hit events defining cancer prevention?The Inhibitor of Apoptosis (IAPs) in Adaptive Response to Cellular Stress cIAP2 as a therapeutic target in colorectal cancer and other malignancies.IAPs on the move: role of inhibitors of apoptosis proteins in cell migration.MicroRNA-34a promotes genomic instability by a broad suppression of genome maintenance mechanisms downstream of the oncogene KSHV-vGPCR.miR-205 suppresses the proliferative and migratory capacity of human osteosarcoma Mg-63 cells by targeting VEGFA.Shikonin inhibits invasiveness of osteosarcoma through MMP13 suppression.p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1.Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR.cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation.Coamplification of Myc/Pvt1 and homozygous deletion of Nlrp1 locus are frequent genetics changes in mouse osteosarcoma.Identification and characterization of the intercellular adhesion molecule-2 gene as a novel p53 target.Cellular uptake on N- and C-termini conjugated FITC of Rath cell penetrating peptides and its consequences for gene-expression profiling in U-937 human macrophages and HeLa cervical cancer cells.Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis.A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.Long noncoding RNA MALAT1 promotes cell proliferation through suppressing miR-205 and promoting SMAD4 expression in osteosarcoma.HIF‑1α‑induced upregulation of lncRNA UCA1 promotes cell growth in osteosarcoma by inactivating the PTEN/AKT signaling pathway.Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.Identification and functional characterization of circRNA-0008717 as an oncogene in osteosarcoma through sponging miR-203.Energy stress-induced lncRNA HAND2-AS1 represses HIF1α-mediated energy metabolism and inhibits osteosarcoma progression.

P2860

Q24306110-369FF4C3-1F4D-4F9A-856E-395565FBE039 Q26745742-8F3BA009-1146-4B71-AD1F-1AFD4EEC3901 Q28396741-94FE38CB-4D65-46F7-B638-FEAAFEEECB73 Q28539741-BE47950C-96F2-4202-BD4C-0DF970F242E7 Q30476415-8DB32B34-A78C-4859-8FFC-4EFBB22D7416 Q33632016-D40122A8-BBEC-4721-87DD-342E2AC2D5C4 Q33747680-3D829D96-D67F-4167-8FC6-59133A03DC8D Q34211970-33771980-008C-4372-B8FE-9491DCDE9A4F Q34259434-31964332-B32A-4091-8E89-52EE74B552F4 Q34425384-F3B2C086-184A-4253-AA83-34033E7A541E Q34575966-0C402EC3-D7B4-4991-9515-573355812FE7 Q34580883-F431C2D7-3E31-4DED-A73F-15AFF1652194 Q35027488-E745F6BC-DB33-439D-8712-F9320AB39B93 Q35070834-40D38522-6D56-409B-8064-ADE0C7FC6A86 Q35088734-A2D42769-5FA8-4847-8731-323A04C93754 Q35414780-617E41E0-7489-443A-8DB4-8D7E515EA5B1 Q35640128-BC082545-06B2-41FE-90E2-CD87BF2AC861 Q36608717-785F8964-AAB7-4592-996B-70F4B5126A40 Q36750689-49BC4BAE-D5E2-4CE6-95A9-4877F409BF21 Q37376164-62B188FA-D278-4280-87F2-77866FD0C2C2 Q37396894-8652A17A-7BF6-4B7C-A342-960DA8807E29 Q37512362-3604EF16-31E1-4260-ADF1-D332A943923A Q37605889-79EE3134-67AC-49D7-908A-0276E8163495 Q38134633-3B1B1E3F-9F8A-45EA-BE8E-E98FF16B7653 Q38794695-467B85B1-9E78-4612-A0A9-BDF15AF8CB88 Q38833391-7B0D9DA4-354E-41AC-A075-BE0A0A8DB832 Q38860724-D8F02D3C-D9D1-4790-AC0E-C3DB44F77CF3 Q38904937-3AA2AC64-3080-4A55-93E6-380C4E53964F Q38931801-830685A5-F027-439D-B1D1-C44DD9720CED Q39266738-8A80DE63-D3C9-4D8F-BFE1-E355DE21B3E6 Q41380246-E71F4B34-B33C-49EB-927A-A42521F9594F Q41854551-B8D8BAA8-8428-438F-B974-B400951A334A Q42251412-0DE200E0-0443-4304-B472-AE2B5421ED54 Q44106136-6EBDEDF4-577D-48B5-A4FF-F4FBD46ED946 Q44481241-4DE0D98A-DFED-43C4-BCA4-A1B10B3BAD3F Q47119874-74CD7CFD-C03B-4ED8-A4BB-C3E3DB0AEE2C Q50067715-D7334572-A067-4996-85FE-0C669888A419 Q54378331-7D8EF762-40A1-457B-B957-75C60F9EF898 Q54970122-1B74E951-D76F-4186-B64C-3318213154A6 Q55026439-3240B172-A087-433D-9A3A-91BA38576A91

P2860

MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression.

http://www.wikidata.org/entity/Q34960600

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.

@ast

MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.

@en

MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.

@nl

type

label

MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.

@ast

MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.

@en

MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.

@nl

prefLabel

MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.

@ast

MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.

@en

MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.

@nl

P1433

Q34960600-716319CB-8F75-4E4A-8977-B30042B21EBC

P1476

Q34960600-9E2AC908-C301-4DDE-969D-43F0408D68CC

P2093

Q34960600-2118CB5B-DCEB-45FE-8BF6-AB39C2CEBD68

Q34960600-4AD884F0-1AE3-4574-9850-4C547CBE5A3B

Q34960600-50810810-D20F-4D76-9427-BBAD35010CDF

Q34960600-547884AD-C7AC-4D47-8BA1-EA5EDC29B511

Q34960600-6D5ED81C-15CE-47B5-BD22-27F6125C235D

Q34960600-965360FB-C1DC-4072-808F-919354D3C550

Q34960600-B89462A7-EB73-4206-8C27-E48623764A6E

Q34960600-DEBB9CA0-E52B-4915-BA6C-C45EBF521515

Q34960600-F361833D-443F-41A1-90A2-9E1AA2420576

Q34960600-FAEADD13-E04C-4C0D-96B8-3B4B4E8D5F65

P2860

Q34960600-0D2EFE6D-3641-4650-9A52-3A128F209350

Q34960600-1B952799-6A18-4BF7-BC56-0B341E4348F1

Q34960600-2441411B-B8D6-4063-9051-63477ECD8560

Q34960600-35D0797B-324A-4AF2-8624-DBEDB2C301A7

Q34960600-36B03346-47E4-4DD2-B963-2EABCDD088A5

Q34960600-455AF403-8EC7-495B-A842-613FBA9C86DB

Q34960600-46F143F5-A473-4783-9998-0A1E8071FAF6

Q34960600-497320A0-97B2-4A02-ABC6-23E4027FA722

Q34960600-4B6F52F0-8C58-41DE-8426-6B6407ABE08F

Q34960600-52CA11FC-290F-4B51-87FA-F174DBEA8393

P304

Q34960600-BE50B613-6E51-437B-AB51-3020CBCDD934

P31

Q34960600-35AEA718-DCEB-439E-B79B-277DCAB341E7

P356

Q34960600-BADD17CA-37E3-45AA-B484-0E41E09FA280

P407

Q34960600-F3CE8592-BCA4-4546-9D34-0F6A243C4467

P433

Q34960600-98894B65-5852-46BF-8A73-52031C69E5DF

P478

Q34960600-E3A6CEE0-F48D-44A7-AEBF-A661874BC3A4

P50

Q34960600-1679B977-78D4-4D15-9180-0F3D50EBA498

P577

Q34960600-53F49796-A7A5-441E-BEA2-6C78127A767E

P5875

Q34960600-15F4330E-8B21-4D21-A97E-1CE399A1F69E

P698

Q34960600-7BD3558C-5ECF-4B06-8FDA-EE2F1820B477

P921

Q34960600-14E0DF97-5835-417B-AEAE-4FEAB6CE70B1

P932

Q34960600-640FDC04-CC2B-4841-B2C5-8B3FFDB575E2

P356

0008-5472.CAN-08-2929

P1433

Cancer Research

P1476

MMP13, Birc2 (cIAP1), and Birc ...... ouse osteosarcoma progression.

@en

P2093

Alan J Herron

http://www.w3.org/2001/XMLSchema#string

Ching C Lau

http://www.w3.org/2001/XMLSchema#string

Jianhe Shen

http://www.w3.org/2001/XMLSchema#string

Lars Zender

http://www.w3.org/2001/XMLSchema#string

Lawrence A Donehower

http://www.w3.org/2001/XMLSchema#string

Ou Ma

http://www.w3.org/2001/XMLSchema#string

Scott W Lowe

http://www.w3.org/2001/XMLSchema#string

Tajhal Dayaram

http://www.w3.org/2001/XMLSchema#string

Tsz-Kwong Man

http://www.w3.org/2001/XMLSchema#string

Wei-Wen Cai

http://www.w3.org/2001/XMLSchema#string

P2860

TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2

IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis

IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis

Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon

Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma

The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP

cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

P304

2559-2567

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-08-2929

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24191540

http://www.w3.org/2001/XMLSchema#string

P698

19276372

http://www.w3.org/2001/XMLSchema#string

P921

P932

2663905

http://www.w3.org/2001/XMLSchema#string